Ingrid Melle Selected Research

Triglycerides (Triacylglycerol)

1/2022	Sex differences in antipsychotic-related triglyceride levels are associated with metabolic hormone differences in patients with severe mental disorders.
1/2021	Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients.
1/2018	Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.
9/2012	Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid Melle Research Topics

Disease

81	Psychotic Disorders (Schizoaffective Disorder) 02/2024 - 05/2003
76	Schizophrenia (Dementia Praecox) 02/2024 - 09/2007
35	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 10/2009
29	Mental Disorders (Mental Disorder) 01/2024 - 11/2009
8	Substance-Related Disorders (Drug Abuse) 01/2023 - 09/2010
5	Wounds and Injuries (Trauma) 01/2023 - 10/2017
5	Cognitive Dysfunction 01/2023 - 01/2012
3	Mood Disorders (Mood Disorder) 06/2023 - 01/2023
3	Inflammation (Inflammations) 01/2023 - 09/2010
2	Genetic Risk Score 01/2024 - 01/2022
2	Neuroinflammatory Diseases 01/2023 - 10/2022
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 02/2016
2	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2010
2	Neurodevelopmental Disorders 01/2022 - 09/2009
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2010
2	Vitamin D Deficiency 01/2018 - 07/2017
2	Vaccinia 01/2016 - 10/2011
2	Necrosis 02/2015 - 09/2010
1	Hallucinations (Hallucination) 03/2024
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2024
1	Vomiting 01/2024
1	Polyuria 01/2024
1	Tachycardia (Tachyarrhythmias) 01/2024
1	Nausea 01/2024
1	Diarrhea 01/2024
1	Polydipsia 01/2024
1	Constipation 01/2024
1	Infections 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022

Drug/Important Bio-Agent (IBA)

39	Polytetrafluoroethylene (Teflon)FDA Link 02/2024 - 01/2009
27	Antipsychotic Agents (Antipsychotics)IBA 02/2024 - 02/2009
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2009
9	LipidsIBA 01/2023 - 01/2018
8	Vitamin D FDA LinkGeneric 06/2023 - 12/2010
8	C-Reactive ProteinIBA 01/2023 - 11/2009
7	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024 - 12/2010
6	CholesterolIBA 01/2022 - 09/2010
5	Antidepressive Agents (Antidepressants)IBA 02/2024 - 06/2011
5	OsteoprotegerinIBA 10/2019 - 09/2010
5	Messenger RNA (mRNA)IBA 01/2019 - 12/2012
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2024 - 01/2022
4	InflammasomesIBA 01/2023 - 01/2022
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 09/2012
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 10/2013
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2016 - 11/2009
4	von Willebrand FactorIBA 05/2016 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2007
3	Olanzapine (Zyprexa)FDA Link 01/2024 - 01/2017
3	Hormones (Hormone)IBA 01/2024 - 01/2022
3	LithiumIBA 01/2023 - 08/2015
3	Cytokine Receptor gp130IBA 01/2022 - 01/2020
3	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2022
3	HDL CholesterolIBA 01/2021 - 09/2012
3	Oxytocin (Pitocin)FDA LinkGeneric 11/2016 - 01/2014
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2016 - 11/2009
3	Genetic Markers (Genetic Marker)IBA 01/2016 - 01/2012
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 11/2009
3	Glucose (Dextrose)FDA LinkGeneric 09/2012 - 05/2008
3	EnzymesIBA 12/2010 - 03/2010
2	Nootropic Agents (Nootropics)IBA 02/2024 - 01/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2024 - 12/2016
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2024 - 01/2017
2	Aripiprazole (Abilify)FDA Link 01/2024 - 01/2017
2	Quetiapine Fumarate (Seroquel)FDA Link 01/2024 - 01/2017
2	Cell Adhesion MoleculesIBA 01/2023 - 10/2022
2	serum P-component (CIt)IBA 01/2023 - 01/2021
2	ChemokinesIBA 01/2023 - 10/2022
2	LigandsIBA 01/2022 - 11/2009
2	oxidized low density lipoproteinIBA 01/2021 - 10/2019
2	Tryptophan (L-Tryptophan)FDA Link 01/2020 - 03/2010
2	Oxytocin Receptors (Oxytocin Receptor)IBA 11/2016 - 01/2015
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2016 - 07/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 10/2011
2	CD40 Ligand (CD40L)IBA 02/2015 - 11/2009
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 05/2012 - 01/2012
2	Transcription Factor 4IBA 10/2011 - 08/2009
2	NeurograninIBA 10/2011 - 08/2009
2	Nerve Growth Factors (Neurotrophins)IBA 02/2011 - 06/2009
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2009 - 01/2009
2	DysbindinIBA 01/2009 - 01/2009
1	Indicators and Reagents (Reagents)IBA 03/2024
1	Hypnotics and Sedatives (Sedatives)IBA 02/2024
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2024
1	Cholinergic Antagonists (Anticholinergics)IBA 02/2024
1	ProlactinIBA 01/2024
1	Insulin (Novolin)FDA Link 01/2024
1	Cell Adhesion Molecule-1IBA 01/2023
1	Nicotine FDA Link 01/2023
1	Fatty Acid-Binding ProteinsIBA 01/2023
1	lipopolysaccharide-binding proteinIBA 01/2023
1	InterleukinsIBA 10/2022
1	DefensinsIBA 10/2022
1	Sp4 Transcription FactorIBA 01/2022
1	B-Cell Activating FactorIBA 01/2022

Therapy/Procedure

11	Transjugular Intrahepatic Portasystemic Shunt 01/2023 - 08/2005
2	Treatment Delay 10/2013 - 09/2010
1	Patient Care 01/2022